<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=612681139262614&amp;ev=PageView&amp;noscript=1">
Skip to content

Need help? Talk to an expert: phone(904) 638-5743

PAPM2

Preserve Every Public Artwork with Confidence.

Government agencies manage growing public art collections across parks, streets, transit systems, government buildings, and community spaces. Disconnected records, delayed inspections, unclear maintenance responsibilities, and missing compliance documentation can put valuable cultural assets and public investments at risk.

Public Art Portfolio Manager brings artwork records, interactive maps, condition inspections, maintenance workflows, funding, compliance insights, and community feedback into one intelligent workspace. Cultural affairs and public works teams can manage every artwork from acquisition and installation through conservation and restoration using Power Apps, Power Automate, and Copilot Studio.

  • Centralize public art records, with artwork profiles, artist details, installation locations, ownership information, photographs, documents, funding sources, and complete activity histories.

  • Protect valuable cultural assets, with mobile inspections, condition assessments, maintenance requests, conservation planning, before-and-after photographs, and automated escalation workflows.

  • Strengthen compliance oversight, with real-time readiness scores, accessibility reviews, insurance and permit monitoring, missing-document alerts, corrective actions, and complete audit histories.

  • Improve portfolio decisions, through interactive maps, animated condition charts, district comparisons, budget insights, executive reports, and Copilot-powered portfolio summaries.

97% of fortune 100 companies trust us

Thousands of companies use Pragmatic Works to learn how to best develop and administer their AI, Power Platform and data systems.

hess
cisco
tyson
rooms-to-go-logo-vector
1-e1605215212348
BGSU-Logo-RGB-JPG
c6526571fbfe5f5db10702af54966e06-g575771g14x91
pfizer